World’s leading cause of total blindness and France’s second leading cause of blindness, glaucoma is a pathology unknown by the public. In France, it is estimated that 1.5 million people are afflicted by glaucoma and half of them are unaware of it.

As every year, for the World Glaucoma Week, Unadev, with support from the French Glaucoma Society (SFG) and the French Glaucoma Association (AFG), is raising public awareness on visual health and early detection of glaucoma. Here’s the program :

– From March 9th to March 15th :
Unadev will inform the public, the patients and their relatives about glaucoma via its social networks :
o Facebook : https://fr.facebook.com/unadevfrance/
o Linkedin : https://www.linkedin.com/company/unadev/mycompany/
o Instagram : https://www.instagram.com/unadev_france/?hl=fr

– Free screening for glaucoma and other blinding pathologies thanks to the ‘Unadev Bus’, a semi-trailer equipped with a receiving area and an ophthalmology office
o from Tuesday 11th to Thursday 13th March in Angoulême
o from Tuesday 25th to Thursday 27th in La Rochelle

– Free screening for glaucoma in rural areas with AFG and supports :
o Friday, March 14th : Maizières-les-Metz
o Saturday, March 15th : Saint-Pourçain-sur-Sioule, Baud and Le Lion d’Angers

_________________

Unadev : The National Union of the Blind and Visually Impaired has been working since 1929 to improve the daily lives of blind and visually impaired people and contributes to their individual and collective development.

_________________

Our preventing campaign : Fourteen years ago, The National Union of the Blind and Visually Impaired set itself the mission of preventing visual impairment raising public awareness of the importance of early detection of glaucoma.
This is why Unadev engaged in a national awareness and free eye diceases screening campaign.
Giving the success of this campaign, Unadev created its ‘Bus’, a semi-trailer equipped with a receiving area and an ophthalmology office.
Since the creation of the ‘Bus’, Unadev has tested 43000 people, including more than 3000 with suspected glaucoma